Neurology Flashcards

1
Q

What is an astrocytoma.

A

Intracranial tumours that are derived from astrocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the demographics of an astrocytoma.

A

They may occur at any age,although they are more common in males.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How can astrocytomas be classified?

A
  • Low grade: Grade I and II, more common in children

- High grade: Grade III and IV, more common in adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the presentation of grade I astrocytomas.

A

Grade I astrocytomas are often found within the cerebellum and as such tend to present with symptoms relating to balance and coordination.

Typically benign in nature.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the presentation of grade II astrocytomas.

A

Grade II tumours often present with seizures and have the potential to become malignant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the pathology behind MS.

A

The Oligodendrocytes degenerate for an unknown reason.

It is an acquired, chronic autoimmune disorder affecting the CNS. It results in demyelination, gliosis and neuronal damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe how a patient with MS would present.

A

Either sensory or motor symptoms as the conduction of signals along a neurone slows down.

Symptoms involve multiple branches of the nervous system, such as vision problems, weakness, pains, tingling and numbness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the pathology behind Alzheimer’s disease.

A

Mass degeneration occurs, commonly targeting the temporal and parietal lobes which cause a wide range of symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the three disease patterns of MS.

A
  1. Relapsing-remitting: Patients face episodes of remission (during which no symptoms are present) and exacerbations of the disease.
  2. Primary progressive: After onset of disease there is steady progression and worsening of the disease.
  3. Secondary Progressive: Initially the MS is of relapsing-remitting pattern however at some point the disease course changes and the neurological function gradually worsens.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give an example of a therapy that has proven useful in terms of managing acute exacerbations of MS.

A

High dose IV corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the pathology behind Guillain-Barré Syndrome.

A

A rapid onset of muscle weakness caused by autoimmune damage to the peripheral nervous system.

The cause is unknown, but the underlying mechanism is damage to the myelin sheath of peripheral nerves by the body’s immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe how a patient with Guillain-Barré Syndrome would present.

A

Initial symptoms usually include changes to sensation or pain and muscle weakness. These begin distally in the feet and hands and then typically spreads proximally to the arms and upper body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe why Guillain-Barré Syndrome can be life threatening in the acute phase.

A

If the respiratory muscles are affected – this requires mechanical ventilation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the treatment options for Guillain-Barré Syndrome.

A
  • Supportive care
  • Plasmapheresis
  • Intravenous immunoglobulins.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name three conditions that Acetylcholinesterase Inhibitors can be used in the treatment of.

A
  1. Myasthenia gravis
  2. Alzheimer’s disease
  3. Glaucoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name some side effects of Acetylcholinesterase Inhibitors.

A
  • Bradycardia
  • Hypotension
  • Diarrhoea
  • Excessive salivation
  • Muscle spasm
17
Q

What does the dorsal column-medial lemniscal pathway (DCML) carry?

A

The sensory modalities of fine touch (tactile sensation), vibration and proprioception

18
Q

What does the anterior spinothalamic tract carry?

A

The sensory modalities of crude touch and pressure.

19
Q

What does the lateral spinothalamic tract carry?

A

The sensory modalities of pain and temperature.

20
Q

What do the spinocerebellar tracts carry?

A

Unconscious proprioceptive information

21
Q

Describe how patient with an injury to the DCML pathway would present.

A

Loss of proprioception and fine touch. However, a small number of tactile fibres travel within the anterolateral system, and so the patient is still able to perform tasks requiring tactile information processing.

If the lesion occurs in the spinal cord (which is most common), the sensory loss will be ipsilateral – decussation occurs in the medulla oblongata.

22
Q

Name some conditions that would result in a DCML lesion.

A
  • Vitamin B12 deficiency

- Tabes dorsalis (a complication of syphilis).

23
Q

Describe how patient with an injury to the anterolateral system would present.

A

Injury to the anterolateral system will produce an impairment of pain and temperature sensation.

This sensory loss will be contralateral (the spinothalamic tracts decussate within the spinal cord).

24
Q

Describe how a patient with Brown-Séquard syndrome would present.

A
  • DCML pathway: ipsilateral loss of touch, vibration and proprioception.
  • Anterolateral system: contralateral loss of pain and temperature sensation.

NOTE: It will also involve the descending motor tracts, causing an ipsilateral hemiparesis.

25
Q

Describe how a patient with a lesions of the spinocerebellar tract would present.

A

Ipsilateral loss of muscle co-ordination.

NOTE: The spinocerebellar pathways are unlikely to be damaged in isolation – there is likely to be additional injury to the descending motor tracts. This will cause muscle weakness or paralysis, and usually masks the loss of muscle co-ordination.

26
Q

Name a common site of cerebrovascular accidents (CVA).

A

The internal capsule.

NOTE: The pyramidal tracts travel through here are therefore are susceptible to damage

27
Q

Name 5 signs of an upper motor neurone lesion.

A
  1. Hypertonia – an increased muscle tone
  2. Hyperreflexia – increased muscle reflexes
  3. Clonus – involuntary, rhythmic muscle contractions
  4. Babinski sign – extension of the hallux in response to blunt stimulation of the sole of the foot
  5. Muscle weakness
28
Q

Describe how a patient with an upper motor neurones for CN XII will present.

A

A lesion to the upper motor neurones for CN XII will result in spastic paralysis of the contralateral genioglossus. This will result in the deviation of the tongue to the contralateral side.

NOTE: this is in contrast to a lower motor neurone lesion, where the tongue deviates towards the damaged side.

29
Q

Describe how a patient with an upper motor neurones for CN VII will present.

A

A lesion to the upper motor neurones for CN VII will result in spastic paralysis of the muscles in the contralateral lower quadrant of the face.